Trial Site Detail
Drug: |
Dasatinib (BMS-354825) |
|||
|---|---|---|---|---|
Trial: |
Phase I (PH I) Mad Refractory Solid Tumor Study |
|||
| Conditions: | Neoplasms | |||
Trial Status: |
Completed |
|||
The Beatson InstituteGarscube Estate Switchback Road Bearsden |
Principal Investigator: |
Jeffrey Evans |
|---|---|
Contact: |
+44 (14) 13304171 j.evans@beatson.gla.ac.uk |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
The Beatson Institute Website: |
http://www.beatson.gla.ac.uk/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.